Drugs in Dev. Hematology
Phase II
Ireland 
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The patent claims describe methods for producing IHAT (Iron Hydroxide Adipate Tartrate), where Generally Recognised As Safe (GRAS) organic acids, and particularly Tartaric and Adipic acids, are used to modify the ferrihydrite nanocore of ferritin.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
December 05, 2021
Lead Product(s) : Iron Hydroxide Adipate Tartrate
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fibrin Sealant (Human)
Therapeutic Area : Hematology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Topical Raplixa for Surgical Bleeding in Children
Details : Undisclosed
Product Name : Raplixa
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 17, 2014
Lead Product(s) : Fibrin Sealant (Human)
Therapeutic Area : Hematology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
